https://fdawatch.net/2026/06/01/fdas-regulatory-revisions-business-legal-impact-on-industry-part-4-consumer-products/FDA Watch Podcasten2026-06-01T13:12:21+00:00FDA’s Regulatory Revisions: Business & Legal Impact on Industry, Part 4 – Consumer ProductsFDA, regulation, FDA Watch, new episode, AI, artificial intelligence, technology, MoCRA, science, design, regulatory policy, education, internet, risk, Skadden, litigation, M&A, mergers, acquisitions, consumer products, BBB National Programs, Rachel Turow, Amy Van Gelder, Brett Fleisher, Katherine Armstrong, deal-making, plaintiffs bar, transactions, social-mediahttps://fdawatch.net/wp-content/uploads/2025/08/fdawatch_artworkupdated8.5.jpg?w=150